Ross JS - Search Results

1

High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.

Hartmaier RJ, Albacker LA, Chmielecki J, Bailey M, He J, Goldberg ME, Ramkissoon S, Suh J, Elvin JA, Chiacchia S, Frampton GM, Ross JS, Miller V, Stephens PJ, Lipson D. Hartmaier RJ, et al. Among authors: ross js. Cancer Res. 2017 May 1;77(9):2464-2475. doi: 10.1158/0008-5472.CAN-16-2479. Epub 2017 Feb 24. Cancer Res. 2017. PMID: 28235761

2

Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.

Ermak G, Gerasimov G, Troshina K, Jennings T, Robinson L, Ross JS, Figge J. Ermak G, et al. Among authors: ross js. Cancer Res. 1995 Oct 15;55(20):4594-8. Cancer Res. 1995. PMID: 7553635

3

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis.

Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifkin MD, Fisher HA. Ross JS, et al. Cancer. 1993 Nov 15;72(10):3020-8. doi: 10.1002/1097-0142(19931115)72:10<3020::aid-cncr2820721026>3.0.co;2-#. Cancer. 1993. PMID: 8106140

4

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.

Ambros RA, Vigna PA, Figge J, Kallakury BV, Mastrangelo A, Eastman AY, Malfetano J, Figge HL, Ross JS. Ambros RA, et al. Among authors: ross js. Cancer. 1994 Mar 15;73(6):1686-92. doi: 10.1002/1097-0142(19940315)73:6<1686::aid-cncr2820730622>3.0.co;2-w. Cancer. 1994. PMID: 8156496

5

Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.

Ermak G, Jennings T, Robinson L, Ross JS, Figge J. Ermak G, et al. Among authors: ross js. Cancer Res. 1996 Mar 1;56(5):1037-42. Cancer Res. 1996. PMID: 8640758

6

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.

Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, Fisher HA, Rifkin MD, Muraca PJ. Ross JS, et al. Cancer. 1997 Jun 1;79(11):2162-70. doi: 10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u. Cancer. 1997. PMID: 9179063

7

Telomerase activity in benign endometrium and endometrial carcinoma.

Brien TP, Kallakury BV, Lowry CV, Ambros RA, Muraca PJ, Malfetano JH, Ross JS. Brien TP, et al. Among authors: ross js. Cancer Res. 1997 Jul 1;57(13):2760-4. Cancer Res. 1997. PMID: 9205088

8

Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.

Tran TA, Kallakury BV, Ambros RA, Ross JS. Tran TA, et al. Among authors: ross js. Cancer. 1998 Jul 15;83(2):276-82. Cancer. 1998. PMID: 9669810

9

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.

Krug LM, Miller VA, Patel J, Crapanzano J, Azzoli CG, Gomez J, Kris MG, Heelan RT, Pizzo B, Tyson L, Sheehan C, Ross JS, Venkatraman E. Krug LM, et al. Among authors: ross js. Cancer. 2005 Nov 15;104(10):2149-55. doi: 10.1002/cncr.21428. Cancer. 2005. PMID: 16208701 Free article. Clinical Trial.

10

Breast cancer biomarkers.

Ross JS, Symmans WF, Pusztai L, Hortobagyi GN. Ross JS, et al. Adv Clin Chem. 2005;40:99-125. doi: 10.1016/s0065-2423(05)40003-7. Adv Clin Chem. 2005. PMID: 16355921 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,779 results

Search Page

Filters